Where is GSK's headquarters located?
GSK maintains its global headquarters at 980 Great West Road in Brentford, located within the western part of the Greater London urban area in the United Kingdom. This prominent corporate campus coordinates the multinational healthcare enterprise's global governance, scientific research pipelines, and strategic business operations. It acts as the core administrative nerve center managing the company's extensive network of offices, laboratories, and production sites spanning over a hundred countries.
Related FAQs
Because "Guaranty Bank" is a very common name for financial institutions in the United States, there have been numerous banks by this name that have been bought out, merged, or rebranded over the decades.
GSK (GlaxoSmithKline) maintains its primary United States regional headquarters and corporate operations center in the historic Navy Yard corporate park located in Philadelphia, Pennsylvania.
Senior executive positions at GlaxoSmithKline, such as the Country General Manager, Vice President of Pharmaceuticals, and regional commercial directors, command the highest salaries within the healthcare and pharmaceutical enterprise.
Equity research analysts tracking GSK stock maintain a balanced consensus, often issuing moderate buy or hold ratings as the company navigates ongoing legal landscapes and executes its biopharma pipeline strategy.
Yes, Guadalupe National Bank offers a modern mobile banking solution that enables customers to securely manage their accounts from their mobile devices.
GSK plc, a leading global biopharmaceutical multinational enterprise dedicated to combining science, technology, and talent to get ahead of disease, has its corporate headquarters located in London, United Kingdom.
GSK plc is frequently evaluated by healthcare sector analysts as a stable long-term investment, supported by a robust portfolio of vaccines, specialty medicines, and general pharmaceutical products.
GSK has implemented targeted, strategic workforce adjustments, including limited research and development role reductions and specific manufacturing site transitions designed to optimize operational productivity.
GSK plc (LSE: GSK) is the stock representing the global biopharma giant GlaxoSmithKline, primarily listed on the London Stock Exchange. As of early August 2026, the company holds a market capitalization of approximately £104.76 billion.
Howmet Aerospace Inc. (HWM) features exceptional growth momentum, with Wall Street analyst consensus price targets tracking strong multi-year upward revisions and upper-bound forecasts reaching high-tier valuations.
GSK and Pfizer are entirely separate, independent multinational pharmaceutical and biotechnology corporations operating under distinct executive leadership, separate corporate headquarters, and individual stock tickers.
GlaxoSmithKline manufactures an extensive and globally vital portfolio of prophylactic vaccines designed to protect populations against a wide variety of infectious diseases across different age groups.
Evaluating whether to sell your shares in GSK plc involves reviewing its global pharmaceutical and vaccine product pipeline, patent expiration timelines, and ongoing litigation risk management.
GlaxoSmithKline (GSK) is a premier global research-based biopharmaceutical company with a history spanning over three centuries. It is most famous for its extensive and impactful portfolio in vaccines and specialty medicines.
Pfizer's legendary cholesterol-lowering medication Lipitor (atorvastatin) stands out as the most commercially successful and widely dispensed pharmaceutical product in modern medical history, accumulating hundreds of billions of dollars in cumulative...
The corporate initials GSK in GSK plc stand for GlaxoSmithKline, which was the official name of the major British multinational pharmaceutical and biotechnology corporation formed through the massive merger of Glaxo Wellcome and SmithKline Beecham.
Yes, GSK plc pays dividends to its shareholders on a quarterly basis. As a major global pharmaceutical company, GSK has a long-standing practice of returning value to its investors through regular dividend payments.
As of early 2026, GSK is ranked as the tenth-largest pharmaceutical company in the world by earnings, recording $9.32 billion in 2025.
The S&P 500 Index (ticker: GSPC), which tracks the 500 largest publicly traded corporations listed on stock exchanges in the United States, represents a multi-trillion-dollar benchmark valuation rather than a single corporate stock.